Home
About us
Our Work
What’s New
Press Releases and Publications
Boards and Committees
Fund Application
Blog
LegCo Business
Statistics
Download Forms
Access to Information
Accessibility of Government Premises, Facilities and Services
Tender Information / Contract Award Notice
Job Opportunities
Related Links
Close submenu
About us
Welcome Message
Biography
Organisation and Functions
Declaration of Interests
Close submenu
Press Releases and Publications
Press Releases
Important Speeches
Consultation Papers
Other Publications
Skip to main content
Text Size
繁
简
Other Languages
Bahasa Indonesia
नेपाली (Nepali)
اردو (Urdu)
ਪੰਜਾਬੀ (Punjabi)
Tagalog
ภาษาไทย (Thai)
हिन्दी (Hindi)
Tiếng Việt (Vietnamese)
Enter search keyword(s)
Languages
繁
简
Bahasa Indonesia
नेपाली (Nepali)
اردو (Urdu)
ਪੰਜਾਬੀ (Punjabi)
Tagalog
ภาษาไทย (Thai)
हिन्दी (Hindi)
Tiếng Việt (Vietnamese)
Search
Enter search keyword(s)
Search All Government
Languages
About us
Welcome Message
Biography
Organisation and Functions
Declaration of Interests
Our Work
What’s New
Press Releases
and Publications
Press Releases
Important Speeches
Consultation Papers
Other Publications
Boards and
Committees
Fund
Application
Blog
Other Publications
Report of the Review Committee on Regulation of Pharmaceutical Products in Hong Kong
< Back
Full Report
(642KB)
By Chapters
Executive Summary
Chapter 1 Introduction
Chapter 2 Existing Regulatory Regime
Chapter 3 Control of Drug Manufacturers and Enhancement to the Good Manufacturing Practices Scheme
Chapter 4 Pre-market Control of Drugs
Chapter 5 Regulation of Importers/Exporters, Wholesalers and Retailers
Chapter 6 Procurement and Supply of Pharmaceutical Products in the Public and Private Medical Sectors
Chapter 7 Post-market Control of Drugs and Pharmacovigilance
Chapter 8 Risk Communication, Education and Training
Chapter 9 Penalty Review
Chapter 10 Resources Implications and Establishment of a Dedicated Office on Drugs
Chapter 11 Summary of Recommendations
Annex A Membership and Terms of Reference of the Review Committee
Annex B Membership of the two Subcommittees
Annex C Membership and Terms of Reference of the Task Force and Expert Group
Annex D Implementation Plans
Annex E Recommendations requiring Legislative Amendments
Annex F Glossary of Terms
Annex G Chronology of Drug Incidents since March 2009
Annex H Drug Registration Certificate
Annex I Existing Organization of the Pharmaceutical Service
Annex J Proposed Organization of the Dedicated Office on Drugs
Close menu